Cohort Company News - MedTech Innovator

Osso VR raises $27M to train surgeons via simulations

DateJul 07 2021

Osso VR has raised $27 million to train doctors and other medical professionals using virtual reality surgery simulations.

Putting digital therapeutics to work for mental health, featuring SilverCloud Health and Xealth

DateJul 07 2021

National Institute of Mental Health data shows that more than 17.3 million U.S. adults have suffered from an episode of major depression in the past year, and one in three are afflicted by an anxiety disorder. Mental health conditions often go underdiagnosed and undertreated.

Alio Raises $20M Series B

DateJun 30 2021

Alio Medical, a wearable technology company enabling greater insights through clinical grade real-time data, announced the close of a Series B financing round totaling $20 million.

Mobility-Enabled Compression Device for Lymphedema: Interview with CEO of Koya Medical

DateJun 23 2021

Koya Medical, a medtech company based in California, has developed the Dayspring active compression system for the treatment of lymphedema.

Onkos Surgical wins FDA clearance for BioGrip 3D-Printed implant

DateJun 22 2021

Onkos Surgical today announced that it received FDA 510(k) clearance for its BioGrip 3D-printed implant technology.

Bone Health Technologies Receives Patent for OsteoBoost Vibration Belt

DateJun 11 2021

Bone Health Technologies, an innovator of progressive new therapies for improving bone health, announced that the United States Patent and Trademark Office (USPTO) has awarded its second patent for the OsteoBoost Vibration Belt.

Vivante Health Expands Product Suite to Include the GIMate

DateJun 11 2021

Vivante Health, the leader in digital medicine for digestive health and disease, proudly announces the GIMate, a first-of-its-kind handheld breath hydrogen monitor. The GIMate device is the newest addition to GIThrive, Vivante’s all-in-one digestive health program for employers and health plans.

Neurescue’s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest

DateJun 10 2021

Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency control of hemorrhage.

Malaysian startup Naluri raises US$5mil in Series A round

DateJun 09 2021

NALURI Hidup Sdn Bhd, a Malaysia-headquartered digital health service provider, today announced the closing of its new, US$5 million (RM20.6 million) funding round.

CloudCath Announces Collaboration with American Renal Associates in Pre-Market Clinical Study for Peritoneal Dialysis Patients

DateJun 08 2021

CloudCath, developer of a remote monitoring and predictive analytics platform for catheter-based treatments, today announced a collaboration with American Renal Associates (ARA), a leading provider of outpatient dialysis services.

A Conversation With Sana Health’s Richard Hanbury

DateJun 08 2021

For me, the Sana Health device was truly a gift from the universe. I’ve been very open about my struggles with pain stemming from my autoimmune disorders and I was extremely grateful when representatives at Sana connected with me and offered to send me a device to help with my healing.

Localized Prostate Cancer Therapy: Interview with Shyam Natarajan, CEO of Avenda Health

DateJun 07 2021

Avenda Health, a medtech company based in Santa Monica, California has developed the Focal Therapy System. It provides AI-powered prostate cancer therapy with the aim of treating only tumorous tissues, while reducing side-effects compared with conventional therapies. The system recently received FDA breakthrough designation.

Medical Device Company FineHeart Successfully Raises €15 million

DateJun 02 2021

FineHeart S.A, a preclinical medical device company that has developed theICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the successful completion of a €15 million funding round.

Empirical Spine Closes $10 Million Series B Financing

DateJun 02 2021

Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced the closing of a Series B financing of $10 million.

Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President

DateJun 02 2021

Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH), today announced that it has closed a $24 million Series B financing round.

PAVmed Launches Digital Health Company Veris Health Inc.

DateJun 02 2021

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the launch of a new subsidiary, digital health company Veris Health Inc. (“Veris”), which acquired Oncodisc Inc. (“Oncodisc”), a digital health company with groundbreaking tools to improve personalized cancer care through remote patient monitoring.

Medical device-maker Allotrope Medical raises $4M Series A round

DateJun 01 2021

Houston-based medical device company Allotrope Medical Inc. raised a $4 million funding round, the firm announced June 1.

Venari Medical: Galway medtech with a potentially life-changing device

DateMay 24 2021

NUI Galway BioInnovate spin-out Venari Medical has developed a minimally invasive medical device that it hopes can tackle CVD at early and extreme stages.

BrainSee Enterprise Software Is Reliable, Accurate for Alzheimer’s Disease Detection, featuring Darmiyan

DateMay 24 2021

Today the American Society of Neuroradiology published Introducing BrainSee, a summary of study results presenting the 91 percent accuracy rate of the new AI-powered and patented technology by Darmiyan Inc. that detects Alzheimer’s disease at early stages of disease development.

Forest Devices Announces That FDA Has Designated the AlphaStroke Technology a Breakthrough Device

DateMay 21 2021

Medical technology pioneer Forest Devices, Inc. (FDI), a medical device company focused on identifying patients with large vessel occlusive (LVO) strokes in the prehospital environment, today announced that the U.S. Food and Drug Administration (FDA) has designated its AlphaStroke technology as a Breakthrough Device.